help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2003-0137
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/9/1751    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, D. A.
Right arrow Articles by Williams, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevens, D. A.
Right arrow Articles by Williams, G. R.
Molecular Endocrinology 17 (9): 1751-1766
Copyright © 2003 by The Endocrine Society

Thyroid Hormone Activates Fibroblast Growth Factor Receptor-1 in Bone

David A. Stevens, Clare B. Harvey, Anthea J. Scott, Patrick J. O’Shea, Joanna C. Barnard, Allan J. Williams, Gerard Brady, Jacques Samarut, Olivier Chassande and Graham R. Williams

Molecular Endocrinology Group (D.A.S., C.B.H., A.J.S., P.J.O’S., J.C.B., A.J.W., G.R.W.), Division of Medicine and Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, United Kingdom; Epistem Ltd. and School of Biological Sciences (G.B.), University of Manchester, Manchester M13 9PT, United Kingdom; Laboratoire de Biologie Moléculaire et Cellulaire de l’ENS de Lyon (J.S., O.C.), Unité Mixte de Recherche 5665 Centre National Recherche Scientifique, LA 913 Institut National de la Recherche Agronomique, 69364 Lyon Cedex 07, France; and Unité Institut National de la Santé et de la Recherche Médicale Unité-443 (O.C.), Université Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex 02, France

Address all correspondence and requests for reprints to: Dr. G. R. Williams, Molecular Endocrinology Group, Medical Research Council Clinical Sciences Centre, Clinical Research Building, 5th Floor, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom. E-mail: graham.williams{at}imperial.ac.uk.

Thyroid hormone (T3) and the T3 receptor (TR) {alpha} gene are essential for bone development whereas adult hyperthyroidism increases the risk of osteoporotic fracture. We isolated fibroblast growth factor receptor-1 (FGFR1) as a T3-target gene in osteoblasts by subtraction hybridization. FGFR1 mRNA was induced 2- to 3-fold in osteoblasts treated with T3 for 6–48 h, and FGFR1 protein was stimulated 2- to 4-fold. Induction of FGFR1 was independent of mRNA half-life and abolished by actinomycin D and cycloheximide, indicating the involvement of an intermediary protein. Fibroblast growth factor 2 (FGF2) stimulated MAPK in osteoblasts, and pretreatment with T3 for 6 h induced a more rapid response to FGF that was increased in magnitude by 2- to 3-fold. Similarly, T3 enhanced FGF2-activated autophosphorylation of FGFR1, but did not modify FGF2-induced phosphorylation of the docking protein FRS2. These effects were abolished by the FGFR-selective inhibitors PD166866 and PD161570. In situ hybridization analyses of TR{alpha}-knockout mice, which have impaired ossification and skeletal mineralization, revealed reduced FGFR1 mRNA expression in osteoblasts and osteocytes, whereas T3 failed to stimulate FGFR1 mRNA or enhance FGF2-activated MAPK signaling in TR{alpha}-null osteoblasts. These findings implicate FGFR1 signaling in T3-dependent bone development and the pathogenesis of skeletal disorders resulting from thyroid disease.

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα
Ligands:   Thyroid hormone



This article has been cited by other articles:


Home page
J EndocrinolHome page
A Scarlett, M P Parsons, P L Hanson, K K Sidhu, T P Milligan, and J M Burrin
Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin {alpha}V{beta}3
J. Endocrinol., March 1, 2008; 196(3): 509 - 517.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. H. D. Bassett, A. J. Williams, E. Murphy, A. Boyde, P. G. T. Howell, R. Swinhoe, M. Archanco, F. Flamant, J. Samarut, S. Costagliola, et al.
A Lack of Thyroid Hormones Rather than Excess Thyrotropin Causes Abnormal Skeletal Development in Hypothyroidism
Mol. Endocrinol., February 1, 2008; 22(2): 501 - 512.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. J. O'Shea, C. J. Guigon, G. R. Williams, and S.-y. Cheng
Regulation of Fibroblast Growth Factor Receptor-1 (Fgfr1) by Thyroid Hormone: Identification of a Thyroid Hormone Response Element in the Murine Fgfr1 Promoter
Endocrinology, December 1, 2007; 148(12): 5966 - 5976.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. H. D. Bassett, K. Nordstrom, A. Boyde, P. G. T. Howell, S. Kelly, B. Vennstrom, and G. R. Williams
Thyroid Status during Skeletal Development Determines Adult Bone Structure and Mineralization
Mol. Endocrinol., August 1, 2007; 21(8): 1893 - 1904.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. H. D. Bassett, P. J. O'Shea, S. Sriskantharajah, B. Rabier, A. Boyde, P. G. T. Howell, R. E. Weiss, J.-P. Roux, L. Malaval, P. Clement-Lacroix, et al.
Thyroid Hormone Excess Rather Than Thyrotropin Deficiency Induces Osteoporosis in Hyperthyroidism
Mol. Endocrinol., May 1, 2007; 21(5): 1095 - 1107.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
B. Rabier, A. J Williams, F. Mallein-Gerin, G. R Williams, and O Chassande
Thyroid hormone-stimulated differentiation of primary rib chondrocytes in vitro requires thyroid hormone receptor {beta}.
J. Endocrinol., October 1, 2006; 191(1): 221 - 228.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. A. Mousa, L. O'Connor, F. B. Davis, and P. J. Davis
Proangiogenesis Action of the Thyroid Hormone Analog 3,5-Diiodothyropropionic Acid (DITPA) Is Initiated at the Cell Surface and Is Integrin Mediated
Endocrinology, April 1, 2006; 147(4): 1602 - 1607.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. J. O'Shea, J. H. D. Bassett, S. Sriskantharajah, H. Ying, S.-y. Cheng, and G. R. Williams
Contrasting Skeletal Phenotypes in Mice with an Identical Mutation Targeted to Thyroid Hormone Receptor {alpha}1 or {beta}
Mol. Endocrinol., December 1, 2005; 19(12): 3045 - 3059.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. C. Barnard, A. J. Williams, B. Rabier, O. Chassande, J. Samarut, S.-y. Cheng, J. H. D. Bassett, and G. R. Williams
Thyroid Hormones Regulate Fibroblast Growth Factor Receptor Signaling during Chondrogenesis
Endocrinology, December 1, 2005; 146(12): 5568 - 5580.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society